XOM — Exxon Mobil Corporation

As of 2026-08-27, the stock sits roughly 11% below its 52-week high after a big run, with RSI at 47.7—neither overbought nor oversold. The Q2 earnings rebound is real, but the consensus 'Hold' rating, a 20x trailing P/E, and analyst debate over whether geopolitical margins will last keep sentiment cautious rather than euphoric.

From 2023 through 2025, quarterly revenue was rangebound around $79–90B and operating margins eroded from ~13% in Q3 2023 to 7.5% by Q4 2025. Q1 2026 was a clear trough: EPS fell to $1.00 and operating margin to 6.4%. Q2 2026 then inflected sharply: revenue jumped 44% YoY to $114.5B, operating income more than doubled to $18.2B, EPS hit $3.48, and operating cash flow reached $23.6B. This is a cyclical/geopolitical rebound, not a smooth multi-year uptrend, and the TTM numbers blend a weak Q1 with an exceptional Q2.

At $156.45 as of 2026-08-27, XOM trades at 20.1x trailing EPS and 1.80x sales, well above its 5-year averages of 12.5x earnings and 1.26x sales. Using the next-FY consensus EPS of $11.55, the forward P/E is about 13.6x—much more reasonable but still not cheap for a cyclical at what may be peak margins. The 2.55% dividend yield provides some floor, but there is no obvious margin of safety.

The market is pricing in continued tight oil markets and strong refining margins. If those hold and XOM earns roughly $11.55 per share, $156.45 is fair to slightly cheap. If supply normalizes and earnings settle closer to $8–9 per share, the stock is effectively at 17–20x earnings and vulnerable. The setup is a bet on supply geopolitics as much as on Exxon's operations.

As of 2026-08-27, RSI(14) is 47.7, so the stock is not overbought or oversold. Price is 9.1% above the 200-day and 4.1% above the 50-day, but 1.8% below the 20-day. That is a longer-term uptrend with a short-term pullback/consolidation. It is not an urgent buy signal; dips toward the 50-day would improve the risk/reward.

• Geopolitical supply disruptions around the Strait of Hormuz have taken roughly 3 million bbl/day offline, boosting crude prices and refining margins.
• U.S. crude inventories at multi-decade lows keep the physical oil market tight in the near term.
• Any normalization/reopening of offline supply or OPEC+ quota increases would quickly compress XOM's upstream and downstream margins.
• Higher-for-longer rates and global demand slowdown fears could weigh on energy demand and valuation multiples.
• Long-term energy-transition policy and capital allocation toward chemicals/M&A add strategic uncertainty.

• Q3 2026 earnings and the annual dividend increase announcement, expected late October/early November 2026, marking year 44 of dividend growth.
• Production growth from the Permian—already above 1.8 mboe/d—and further Guyana offshore expansion milestones.
• Potential $8B acquisition of Shell's U.S. chemical assets, which could reshape XOM's chemicals business.
• Further escalation OR de-escalation of Middle East supply disruptions—both would move earnings power materially.

• Sudden normalization of global supply disruptions, which would depress refining margins and crude prices simultaneously.
• Global recession or demand destruction hitting oil, gas, and chemical volumes.
• Operational outages or logistics blockages—Q1 2026 is a reminder of how much earnings can swing on these issues.
• Valuation mean reversion: at 20x trailing earnings versus a 12.5x 5-year average, an earnings miss could hit the stock hard.
• Long-term regulatory/carbon-policy pressure and energy-transition capital costs.

XOM is a high-quality, conservatively financed cash generator with a defensive balance sheet and a reliable dividend. The main problem is timing: the current earnings spike is heavily tied to geopolitical supply outages, and the stock is priced for that to continue. At $156.45 as of 2026-08-27, it is a reasonable hold but not a compelling new buy; I would be more interested closer to $145–150.

I applied a 14.0x forward P/E to the next-FY consensus EPS of $11.55. The 14.0x multiple is about 1.5 turns above XOM's 5-year average P/E of 12.5x, justified by low leverage and strong free cash flow, but below the current 20x trailing multiple because the Q2 geopolitical margin spike should not be treated as permanent. This yields $161.66.